Cargando…

Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study

OBJECTIVE: The aim of this study is to describe the connotations of health beliefs about adjuvant endocrine therapy (AET) in premenopausal breast cancer survivors in Northeast China and to explore the reasons underlying bad behaviours and influential factors of AET adherence and persistence. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lei, Wang, Aiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743632/ https://www.ncbi.nlm.nih.gov/pubmed/31564839 http://dx.doi.org/10.2147/PPA.S217562

Ejemplares similares

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
por: Lambert, Leah K., et al.
Publicado: (2018)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Self-Management About Adjuvant Therapy in Breast Cancer Survivors: A Qualitative Study
por: Jia, Lingying, et al.
Publicado: (2022)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
por: Pelizzari, Giacomo, et al.
Publicado: (2018)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors
por: Sella, Tal, et al.
Publicado: (2023)

Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer
por: Lee, Young-Won, et al.
Publicado: (2023)

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer
por: Forward, D P, et al.
Publicado: (2004)

Psychometric properties of the Beliefs about Medicine Questionnaire–adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer
por: Brett, Jo, et al.
Publicado: (2017)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases
por: MADEDDU, CLELIA, et al.
Publicado: (2014)

Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory
por: AlOmeir, Othman, et al.
Publicado: (2020)

Women’s Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions
por: Humphries, Brittany, et al.
Publicado: (2018)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
por: Matthews, Anthony, et al.
Publicado: (2018)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

The relationship between work-related outcomes and symptoms in early breast cancer survivors receiving adjuvant endocrine therapy
por: Nakao, Mayumi, et al.
Publicado: (2022)

Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom
por: McGuinness, Serena, et al.
Publicado: (2022)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
por: Buono, Giuseppe, et al.
Publicado: (2022)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.
por: Bruning, P. F., et al.
Publicado: (1990)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
por: Toivonen, Kirsti I., et al.
Publicado: (2020)

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
por: Uchino, J., et al.
Publicado: (1994)

A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1990)

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
por: Pagani, Olivia, et al.
Publicado: (2020)

Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies
por: Wang, Kaiyue, et al.
Publicado: (2022)

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer
por: Hackshaw, Allan, et al.
Publicado: (2009)

Hobson’s choice or a horned dilemma: a grounded theory on adherence to adjuvant endocrine therapy verified with breast cancer survivors
por: AlOmeir, Othman, et al.
Publicado: (2022)

Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
por: Eom, Kirsten Y., et al.
Publicado: (2021)

Beliefs and Behaviors about Breast Cancer Recurrence Risk Reduction among African American Breast Cancer Survivors
por: Ansa, Benjamin, et al.
Publicado: (2015)

A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy
por: Pieters, Huibrie C., et al.
Publicado: (2019)

Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
por: Matthews, Anthony A, et al.
Publicado: (2021)

A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer
por: Harrow, Alison, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4thh3k2gisb5m9gb8ildfbuv0s